Full Access

Serum sickness-like illness following streptokinase therapy. A case report

Corresponding Author

J.D. CREAMER

St John's Institute of Dermatology, St Thomas' Hospital, London UK

Dr J.D. Creamer, St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK.Search for more papers by this author

J.A. MCGRATH,

J.A. MCGRATH

St John's Institute of Dermatology, St Thomas' Hospital, London UK

Search for more papers by this author

M. WEBB-PEPLOE,

M. WEBB-PEPLOE

Department of Cardiology, St Thomas' Hospital, London UK

Search for more papers by this author

N.P. SMITH,

N.P. SMITH

St John's Institute of Dermatology, St Thomas' Hospital, London UK

Search for more papers by this author

J.D. CREAMER,

Corresponding Author

J.D. CREAMER

St John's Institute of Dermatology, St Thomas' Hospital, London UK

Dr J.D. Creamer, St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK.Search for more papers by this author

J.A. MCGRATH,

J.A. MCGRATH

St John's Institute of Dermatology, St Thomas' Hospital, London UK

Search for more papers by this author

M. WEBB-PEPLOE,

M. WEBB-PEPLOE

Department of Cardiology, St Thomas' Hospital, London UK

Search for more papers by this author

N.P. SMITH,

N.P. SMITH

St John's Institute of Dermatology, St Thomas' Hospital, London UK

Search for more papers by this author

First published: November 1995

https://doi.org/10.1111/j.1365-2230.1995.tb01379.x

Citations: 2

About

PDF

Tools

Share a link

Email
Wechat
Bluesky

Summary

We report a patient who developed a serum sickness-like illness characterized by fever, arthritis, haematuria and a purpuric eruption 7 days following streptokinase therapy for myocardial infarction. Blood tests demonstrated increased circulating immune complexes. The skin involvement resulted in extensive, painful cutaneous infarction with secondary bacterial infection. Serum sickness is an uncommon but recognized complication of streptokinase therapy.

References

1 Curry N, Bardana KJ, Pirofsky B. Heparin sensitivity. Arch Intern Med 1973; 132: 744–5.
CAS PubMed Web of Science® Google Scholar
2 Bircher AJ, Fluckiger R, Buchner SA. Eczematous infiltrated plaques to subcutaneous heparin: a type IV reaction. Br J Dermatol 123: 507–14.
Google Scholar
3 McGrath KG, Zeffren B, Alexander J et al. Allergic reactions to streptokinase consistent with anaphylactic or antigen-antibody complex-mediated damage. J Allergy Clin Immunol 1985; 76: 453–7.
10.1016/0091-6749(85)90726-2
CAS PubMed Web of Science® Google Scholar
4 International Study of Infarct Survival (ISIS) Collaborative Group. Randomised trial of intravenous streptokinase, oral asprin, both or neither among 17,182 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 149–60.
Google Scholar
5 Totty WG, Romano T, Benian GM et al. Serum sickness following streptokinase therapy. AJR 1982; 138: 143–4.
10.2214/ajr.138.1.143
CAS PubMed Web of Science® Google Scholar
6 Alexopoulos D, Raine AEG, Cobbe SM. Serum sickness complicating intravenous streptokinase therapy in acute myocardial infarction. Eur Heart J 1984; 5: 1010–2.
CAS PubMed Web of Science® Google Scholar
7 Thompson RF, Stratum MA, Heffron WA Hypersensitivity vasculitis associated with streptokinase. Clin Pharm l985; 4: 383–8.
Google Scholar
8 Patel A, Prussick R, Buchanan WW, Sauder DN Scrum sickness-like illness and leucocytoclastic vasculitis after intravenous streptokinase. J Am Acad Dermatol 24: 652–3.
Google Scholar
9 Bucknall C, Darley C, Flax J et al. Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Br Heart J 1988; 59: 9–11.
10.1136/hrt.59.1.9
CAS PubMed Web of Science® Google Scholar
10 Manoharan A, Ramsay D, Davis S, Lvoff R Hypersensitivity vasculitis associated with streptokinase. Aust NZ J Med 1986; 16: 815–16.
10.1111/j.1445-5994.1986.tb00050.x
CAS PubMed Web of Science® Google Scholar
11 Clesham GL, Terry HJ, Jalihal S, Toghill PJ Serum sickness and purpura following intravenous streptokinase. J R Soc Med 1992; 85: 638–9.
CAS PubMed Web of Science® Google Scholar
12 Noel J, Rosenbaum LH, Gangadharan V et al. Serum sickness–like illness and leucocytoclastic vasculitis following intracoronary arterial streptokinase. Am Heart J 1987; 113: 395–6.
10.1016/0002-8703(87)90287-0
CAS PubMed Web of Science® Google Scholar
13 Dixon FJ, Cochrane CC, Theofilopoulos AN Immune complex injury. In: M Samter, DW Talmage, MM Frank et al., eds.. Immunological Diseases. Boston : Little Brown and Co., 1988; 233–59.
Web of Science® Google Scholar
14 Erffmeyer JE. Serum sickness. Ann Allergy 1986; 56: 105–9.
PubMed Web of Science® Google Scholar
15 Lawley TJ, Bietory L, Gascon P et al. A prospective clinical and immunological analysis of patients with serum sickness. N Engl J Med 1984; 311: 1407–13.
10.1056/NEJM198411293112204
PubMed Web of Science® Google Scholar
16 Dykewicz MS, McGrath KG, Davison R et al. Identification of patients at risk for anaphylaxis due to streptokinase. Arch Intern Med 1986; 146: 305–7.
10.1001/archinte.1986.00360140127018
CAS PubMed Google Scholar

Citing Literature

Volume20, Issue6

November 1995

Pages 468-470

Serum sickness-like illness following streptokinase therapy. A case report

Summary

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Serum sickness-like illness following streptokinase therapy. A case report

Summary

References

Citing Literature

References

Related

Information